SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-019359
Filing Date
2016-05-13
Accepted
2016-05-13 16:01:20
Documents
64
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q alxa-10q_20160331.htm 10-Q 1603583
2 EX-10.1 alxa-ex101_579.htm EX-10.1 242453
3 EX-10.2 alxa-ex102_578.htm EX-10.2 65784
4 EX-10.3 alxa-ex103_580.htm EX-10.3 96495
5 EX-10.4 alxa-ex104_581.htm EX-10.4 345763
6 EX-31.1 alxa-ex311_295.htm EX-31.1 8972
7 EX-31.2 alxa-ex312_181.htm EX-31.2 8558
8 EX-32.1 alxa-ex321_183.htm EX-32.1 5028
  Complete submission text file 0001564590-16-019359.txt   6331456

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT alxa-20160331.xml EX-101.INS 1020474
10 XBRL TAXONOMY EXTENSION SCHEMA alxa-20160331.xsd EX-101.SCH 44604
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alxa-20160331_cal.xml EX-101.CAL 40365
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alxa-20160331_def.xml EX-101.DEF 163521
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE alxa-20160331_lab.xml EX-101.LAB 358823
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alxa-20160331_pre.xml EX-101.PRE 284311
Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043 650.944.7000
Alexza Pharmaceuticals Inc. (Filer) CIK: 0001344413 (see all company filings)

IRS No.: 770567768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51820 | Film No.: 161648247
SIC: 2834 Pharmaceutical Preparations